Insulin resistance, inflammation, and obesity: Role of monocyte chemoattractant protein-1 (orCCL2) in the regulation of metabolism

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Rull, Anna ^a   Camps, Jordi ^a   Alonso Villaverde, Carlos ^b   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL SON LLÀTZER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADIPOSE TISSUE; APOPTOSIS; AUTOPHAGY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CELL INFILTRATION; CHEMOTAXIS; CHRONIC INFLAMMATION; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HUMAN; IMMUNE RESPONSE; INSULIN RESISTANCE; LIPID PEROXIDATION; MACROPHAGE; MAST CELL; METABOLIC DISORDER; METABOLIC REGULATION; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION;

AUTOPHAGY; CHEMOKINE CCL2; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGES; OBESITY;

EID: 78349279253     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/326580     Document Type: Review

References (88)

1. Medzhitov R., Origin and physiological roles of inflammation Nature 2008 454 7203 428 435
2. Hofmann M. A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M. F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A. M., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 1999 97 7 889 901
3. Yan S. F., Ramasamy R., Schmidt A. M., Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications Nature Clinical Practice Endocrinology and Metabolism 2008 4 5 285 293
4. Navab M., Anantharamaiah G. M., Reddy S. T., Van Lenten B. J., Ansell B. J., Fogelman A. M., Mechanisms of disease: proatherogenic HDLan evolving field Nature Clinical Practice Endocrinology and Metabolism 2006 2 9 504 511
5. Camps J., Marsillach J., Joven J., The paraoxonases: role in human diseases and methodological difficulties in measurement Critical Reviews in Clinical Laboratory Sciences 2009 46 2 83 106
6. Turnbull A. V., Rivier C. L., Regulation of the hypothalamic-pituitary- adrenal axis by cytokines: actions and mechanisms of action Physiological Reviews 1999 79 1 1 71
7. Gordon S., Taylor P. R., Monocyte and macrophage heterogeneity Nature Reviews Immunology 2005 5 12 953 964
8. Chen A., Mumick S., Zhang C., Diet induction of monocyte chemoattractant protein-1 and its impact on obesity Obesity Research 2005 13 8 1311 1320
9. Rull A., Rodrguez F., Aragons G., Marsillach J., Beltrn R., Alonso-Villaverde C., Camps J., Joven J., Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis Cytokine 2009 48 3 273 279
10. Majno G., Joris I., Apoptosis, oncosis, and necrosis: an overview of cell death American Journal of Pathology 1995 146 1 3 15
11. Henson P. M., Hume D. A., Apoptotic cell removal in development and tissue homeostasis Trends in Immunology 2006 27 5 244 250
12. Tuncman G., Hirosumi J., Solinas G., Chang L., Karin M., Hotamisligil G. S., Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance Proceedings of the National Academy of Sciences of the United States of America 2006 103 28 10741 10746
13. Hirosumi J., Tuncman G., Chang L., Grgn C. Z., Uysal K. T., Maeda K., Karin M., Hotamisligil G. S., A central, role for JNK in obesity and insulin resistance Nature 2002 420 6913 333 336
14. zcan U., Cao Q., Yilmaz E., Lee A.-H., Iwakoshi N. N., zdelen E., Tuncman G., Grgn C., Glimcher L. H., Hotamisligil G. S., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes Science 2004 306 5695 457 461
15. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M., Increased adipose tissue expression of tumor necrosis factor- in human obesity and insulin resistance Journal of Clinical Investigation 1995 95 5 2409 2415
16. Uysal K. T., Wiesbrock S. M., Marino M. W., Hotamisligil G. S., Protection from obesity-induced insulin resistance in mice lacking TNF- function Nature 1997 389 6651 610 614
17. Ron D., Walter P., Signal integration in the endoplasmic reticulum unfolded protein response Nature Reviews Molecular Cell Biology 2007 8 7 519 529
18. Schrder M., Kaufman R. J., The mammalian unfolded protein response Annual Review of Biochemistry 2005 74 739 789
19. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 2006 440 7086 944 948
20. Zhang K., Shen X., Wu J., Sakaki K., Saunders T., Rutkowski D. T., Back S. H., Kaufman R. J., Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response Cell 2006 124 3 587 599
21. Lipson K. L., Ghosh R., Urano F., The role of IRE1 in the degradation of insulin mRNA in pancreatic -cells PLoS ONE 2008 3 2
22. Erbay E., Babaev V. R., Mayers J. R., Makowski L., Charles K. N., Snitow M. E., Fazio S., Wiest M. M., Watkins S. M., Linton M. F., Hotamisligil G. S., Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis Nature Medicine 2009 15 12 1383 1391
23. Reiling J. H., Sabatini D. M., Stress and mTORture signaling Oncogene 2006 25 48 6373 6383
24. Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., Tanaka K., Cuervo A. M., Czaja M. J., Autophagy regulates lipid metabolism Nature 2009 458 7242 1131 1135
25. Singh R., Xiang Y., Wang Y., Baikati K., Cuervo A. M., Luu Y. K., Tang Y., Pessin J. E., Schwartz G. J., Czaja M. J., Autophagy regulates adipose mass and differentiation in mice Journal of Clinical Investigation 2009 119 11 3329 3339
26. Lumeng C. N., DeYoung S. M., Bodzin J. L., Saltiel A. R., Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity Diabetes 2007 56 1 16 23
27. Gordon S., Taylor P. R., Monocyte and macrophage heterogeneity Nature Reviews Immunology 2005 5 12 953 964
28. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M., The chemokine system in diverse forms of macrophage activation and polarization Trends in Immunology 2004 25 12 677 686
29. Lumeng C. N., Bodzin J. L., Saltiel A. R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization Journal of Clinical Investigation 2007 117 1 175 184
30. Lumeng C. N., Delproposto J. B., Westcott D. J., Saltiel A. R., Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes Diabetes 2008 57 12 3239 3246
31. Tsou C.-L., Peters W., Si Y., Slaymaker S., Aslanian A. M., Weisberg S. P., Mack M., Charo I. F., Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites Journal of Clinical Investigation 2007 117 4 902 909
32. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., Yoshimura K., Kadowaki T., Nagai R., CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity Nature Medicine 2009 15 8 914 920
33. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., Maezawa Y., Drucker D. J., Engleman E., Winer D., Dosch H.-M., Normalization of obesity-associated insulin resistance through immunotherapy Nature Medicine 2009 15 8 921 929
34. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A. B., Benoist C., Shoelson S., Mathis D., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters Nature Medicine 2009 15 8 930 939
35. Liu J., Divoux A., Sun J., Zhang J., Clment K., Glickman J. N., Sukhova G. K., Wolters P. J., Du J., Gorgun C. Z., Doria A., Libby P., Blumberg R. S., Kahn B. B., Hotamisligil G. S., Shi G.-P., Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice Nature Medicine 2009 15 8 940 945
36. Desprs J.-P., Lemieux I., Abdominal obesity and metabolic syndrome Nature 2006 444 7121 881 887
37. Hanson R. L., Imperatore G., Bennett P. H., Knowler W. C., Components of the metabolic syndrome and incidence of type 2 diabetes Diabetes 2002 51 10 3120 3127
38. Zheng Y., Chaudhry A., Kas A., DeRoos P., Kim J. M., Chu T.-T., Corcoran L., Treuting P., Klein U., Rudensky A. Y., Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses Nature 2009 458 7236 351 356
39. Piccirillo C. A., d'Hennezel E., Sgouroudis E., Yurchenko E., CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas Current Opinion in Immunology 2008 20 6 655 662
40. Tran T. T., Yamamoto Y., Gesta S., Kahn C. R., Beneficial effects of subcutaneous fat transplantation on metabolism Cell Metabolism 2008 7 5 410 420
41. Bosello O., Zamboni M., Visceral obesity and metabolic syndrome Obesity Reviews 2000 1 1 47 56
42. Geissmann F., Jung S., Littman D. R., Blood monocytes consist of two principal subsets with distinct migratory properties Immunity 2003 19 1 71 82
43. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J.-L., Bouloumi A., Barbatelli G., Cinti S., Svensson P.-A., Barsh G. S., Zucker J.-D., Basdevant A., Langin D., Clment K., Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss Diabetes 2005 54 8 2277 2286
44. Rausch M. E., Weisberg S., Vardhana P., Tortoriello D. V., Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration International Journal of Obesity 2008 32 3 451 463
45. Yu X., Dluz S., Graves D. T., Zhang L., Antoniades H. N., Hollander W., Prusty S., Valente A. J., Schwartz C. J., Sonenshein G. E., Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates Proceedings of the National Academy of Sciences of the United States of America 1992 89 15 6953 6957
46. Gu L., Okada Y., Clinton S. K., Gerard C., Sukhova G. K., Libby P., Rollins B. J., Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Molecular Cell 1998 2 2 275 281
47. C. Dawson T., A. Kuziel W., A. Osahar T., Maeda N., Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice Atherosclerosis 1999 143 1 205 211
48. Boring L., Gosling J., Cleary M., Charo I. F., Decreased lesion formation in CCR2(-/-) mice reveals a role for chemokines in the initiation of atherosclerosis Nature 1998 394 6696 894 897
49. Han K. H., Tangirala R. K., Green S. R., Quehenberger O., Chemokine receptor CCR2 expression and monocyte chemoattractant protein- 1-mediated chemotaxis in human monocytes: a regulatory role for plasma LDL Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 12 1983 1991
50. Rull A., Beltrn-Debn R., Aragons G., Rodrguez-Sanabria F., Alonso-Villaverde C., Camps J., Joven J., Expression of cytokine genes in the aorta is altered by the deficiency in MCP-1: effect of a high-fat, high-cholesterol diet Cytokine 2010 50 2 121 128
51. Piemonti L., Leone B. E., Nano R., Saccani A., Monti P., Maffi P., Bianchi G., Sica A., Peri G., Melzi R., Aldrighetti L., Secchi A., Di Carlo V., Allavena P., Bertuzzi F., Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation Diabetes 2002 51 1 55 65
52. Barna B. P., Pettay J., Barnett G. H., Zhou P., Iwasaki K., Estes M. L., Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor Journal of Neuroimmunology 1994 50 1 101 107
53. Brown Z., Robson R. L., Westwick J., Regulation and expression of chemokines: potential role in glomerulonephritis Journal of Leukocyte Biology 1996 59 1 75 80
54. Cushing S. D., Berliner J. A., Valente A. J., Territo M. C., Navab M., Parhami F., Gerrity R., Schwartz C. J., Fogelman A. M., Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells Proceedings of the National Academy of Sciences of the United States of America 1990 87 13 5134 5138
55. Coll B., Alonso-Villaverde C., Joven J., Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker? Clinica Chimica Acta 2007 383 1-2 21 29
56. Marsillach J., Bertran N., Camps J., Ferr N., Riu F., Tous M., Coll B., Alonso-Villaverde C., Joven J., The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease Clinical Biochemistry 2005 38 12 1138 1140
57. Sartipy P., Loskutoff D. J., Monocyte chemoattractant protein 1 in obesity and insulin resistance Proceedings of the National Academy of Sciences of the United States of America 2003 100 12 7265 7270
58. Lu B., Rutledge B. J., Gu L., Fiorillo J., Lukacs N. W., Kunkel S. L., North R., Gerard C., Rollins B. J., Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice Journal of Experimental Medicine 1998 187 4 601 608
59. Takahashi K., Mizuarai S., Araki H., Mashiko S., Ishihara A., Kanatani A., Itadani H., Kotani H., Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice Journal of Biological Chemistry 2003 278 47 46654 46660
60. Bruun J. M., Lihn A. S., Pedersen S. B., Richelsen B., Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT Journal of Clinical Endocrinology and Metabolism 2005 90 4 2282 2289
61. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K.-I., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity Journal of Clinical Investigation 2006 116 6 1494 1505
62. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., Oishi Y., Nishimura S., Manabe I., Hashimoto H., Ohnishi Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Nagai R., Kadowaki T., Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance Journal of Biological Chemistry 2006 281 36 26602 26614
63. Weisberg S. P., Hunter D., Huber R., CCR2 modulates inflammatory and metabolic effects of high-fat feeding Journal of Clinincal Investigation 2006 116 1 115 124
64. Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D., Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids Proceedings of the National Academy of Sciences of the United States of America 1984 81 12 3883 3887
65. Rong J. X., Berman J. W., Taubman M. B., Fisher E. A., Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 10 1617 1623
66. Sears D. D., Miles P. D., Chapman J., Ofrecio J. M., Almazan F., Thapar D., Miller Y. I., 12/15-lipoxygenase is equired for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice PLoS ONE 2009 4 9
67. Inouye K. E., Shi H., Howard J. K., Daly C. H., Lord G. M., Rollins B. J., Flier J. S., Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue Diabetes 2007 56 9 2242 2250
68. Rull A., Escol-Gil J. C., Julve J., Rotllan N., Calpe-Berdiel L., Coll B., Aragons G., Marsillach J., Alonso-Villaverde C., Camps J., Blanco-Vaca F., Joven J., Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism Experimental and Molecular Pathology 2007 83 3 361 366
69. Niu J., Kolattukudy P. E., Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications Clinical Science 2009 117 3 95 109
70. Salcedo R., Ponce M. L., Young H. A., Wasserman K., Ward J. M., Kleinman H. K., Oppenheim J. J., Murphy W. J., Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression Blood 2000 96 1 34 40
71. Azfer A., Niu J., Rogers L. M., Adamski F. M., Kolattukudy P. E., Activation of endoplasmic reticulum stress response during the development of ischemic heart disease American Journal of Physiology 2006 291 3 H1411 H1420
72. Morimoto H., Takahashi M., Izawa A., Ise H., Hongo M., Kolattukudy P. E., Ikeda U., Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction Circulation Research 2006 99 8 891 899
73. Dewald O., Zymek P., Winkelmann K., Koerting A., Ren G., Abou-Khamis T., Michael L. H., Rollins B. J., Entman M. L., Frangogiannis N. G., CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts Circulation Research 2005 96 8 881 889
74. Zhou L., Azfer A., Niu J., Graham S., Choudhury M., Adamski F. M., Younce C., Binkley P. F., Kolattukudy P. E., Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction Circulation Research 2006 98 9 1177 1185
75. Younce C. W., Kolattukudy P. E., MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP Biochemical Journal 2010 426 1 43 53
76. Roca H., Varsos Z. S., Mizutani K., Pienta K. J., CCL2, survivin and autophagy: new links with implications in human cancer Autophagy 2008 4 7 969 971
77. Kurihara T., Bravo R., Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC Journal of Biological Chemistry 1996 271 20 11603 11606
78. Rot A., Contribution of Duffy antigen to chemokine function Cytokine and Growth Factor Reviews 2005 16 6 687 694
79. Mantovani A., Bonecchi R., Locati M., Tuning inflammation and immunity by chemokine sequestration: decoys and more Nature Reviews Immunology 2006 6 12 907 918
80. Pruenster M., Mudde L., Bombosi P., Dimitrova S., Zsak M., Middleton J., Richmond A., Graham G. J., Segerer S., Nibbs R. J. B., Rot A., The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity Nature Immunology 2009 10 1 101 108
81. Joven J., Coll B., Tous M., Ferr N., Alonso-Villaverde C., Parra S., Camps J., The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis Clinica Chimica Acta 2006 368 1-2 114 119
82. Schnabel R. B., Baumert J., Barbalic M., Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators Blood 2010 115 26 5289 5299
83. Tateya S., Tamori Y., Kawaguchi T., Kanda H., Kasuga M., An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice Endocrinology 2010 151 3 971 979
84. Dawson J., Miltz W., Mir A. K., Wiessner C., Targeting monocyte chemoattractant protein-1 signalling in disease Expert Opinion on Therapeutic Targets 2003 7 1 35 48
85. Ohtani K., Usui M., Nakano K., Kohjimoto Y., Kitajima S., Hirouchi Y., Li X.-H., Kitamoto S., Takeshita A., Egashira K., Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys Gene Therapy 2004 11 16 1273 1282
86. Tamura Y., Sugimoto M., Murayama T., Ueda Y., Kanamori H., Ono K., Ariyasu H., Akamizu T., Kita T., Yokode M., Arai H., Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 12 2195 2201
87. Beltrn-Debn R., Alonso-Villaverde C., Aragons G., Rodrguez-Medina I., Rull A., Micol V., Segura-Carretero A., Fernndez-Gutirrez A., Camps J., Joven J., The aqueous extract of Hibiscus sabdariffa calices modulates the production of monocyte chemoattractant protein-1 in humans Phytomedicine 2009 17 186 191
88. Kanamori H., Matsubara T., Mima A., Sumi E., Nagai K., Takahashi T., Abe H., Iehara N., Fukatsu A., Okamoto H., Kita T., Doi T., Arai H., Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy Biochemical and Biophysical Research Communications 2007 360 4 772 777